Scarica l'app Stockscreener
9.04
9.69%
-0.97
Dopo l'orario di chiusura:
9.00
-0.04
-0.44%
Precedente Chiudi:
$10.01
Aprire:
$9.39
Volume 24 ore:
2.24M
Relative Volume:
2.54
Capitalizzazione di mercato:
$488.17M
Reddito:
-
Utile/perdita netta:
$-86.60M
Rapporto P/E:
-3.1916
EPS:
-2.8324
Flusso di cassa netto:
$-67.37M
1 W Prestazione:
-8.13%
1M Prestazione:
+36.56%
6M Prestazione:
+94.83%
1 anno Prestazione:
+14.00%
Intervallo 1D:
$8.785
$9.40
Intervallo di 1 settimana:
$8.785
$10.38
Portata 52W:
$1.45
$11.72
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
Nome
Lexeo Therapeutics Inc
Settore
Industria
Telefono
(212) 547-9879
Indirizzo
345 PARK AVENUE SOUTH, NEW YORK
Confronta LXEO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
9.04 | 720.42M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-15 | Iniziato | Guggenheim | Buy |
| 2025-07-31 | Iniziato | Oppenheimer | Outperform |
| 2024-06-13 | Iniziato | Robert W. Baird | Outperform |
| 2024-06-06 | Iniziato | H.C. Wainwright | Buy |
| 2023-11-28 | Iniziato | Chardan Capital Markets | Buy |
| 2023-11-28 | Iniziato | JP Morgan | Overweight |
| 2023-11-28 | Iniziato | Leerink Partners | Outperform |
| 2023-11-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-11-28 | Iniziato | Stifel | Buy |
Mostra tutto
Lexeo Therapeutics Inc Borsa (LXEO) Ultime notizie
Long term hold vs stop loss in Lexeo Therapeutics Inc.Gap Down & AI Driven Stock Reports - newser.com
How Lexeo Therapeutics Inc. stock reacts to bond yieldsMarket Risk Summary & Technical Buy Zone Confirmations - newser.com
Can Lexeo Therapeutics Inc. stock withstand economic slowdown2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Using Python tools to backtest Lexeo Therapeutics Inc. strategiesChart Signals & Comprehensive Market Scan Reports - newser.com
Using Ichimoku Cloud for Lexeo Therapeutics Inc. technicalsPortfolio Value Report & Real-Time Market Trend Scan - newser.com
Multi asset correlation models including Lexeo Therapeutics Inc.July 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Is Lexeo Therapeutics (LXEO) One of Billionaire Daniel Sundheim’s Stock Picks with Huge Upside Potential - Yahoo Finance
Will Lexeo Therapeutics Inc. price bounce be sustainableTrade Volume Summary & Verified Technical Trade Signals - newser.com
Using data filters to optimize entry into Lexeo Therapeutics Inc.Portfolio Return Summary & Verified Momentum Stock Ideas - newser.com
Will Lexeo Therapeutics Inc. stock outperform Nasdaq index2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Should you hold or exit Lexeo Therapeutics Inc. nowWeekly Volume Report & Risk Managed Investment Strategies - newser.com
What to do if you’re stuck in Lexeo Therapeutics Inc.2025 Top Decliners & Daily Risk Controlled Trade Plans - newser.com
Why hedge funds are buying Lexeo Therapeutics Inc. stockQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
Best data tools to analyze Lexeo Therapeutics Inc. stockGap Down & Weekly Return Optimization Plans - newser.com
Real time pattern detection on Lexeo Therapeutics Inc. stock2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com
Can Lexeo Therapeutics Inc. stock double in next 5 yearsJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo T - GuruFocus
RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo Therapeutics Inc - GuruFocus
Is Lexeo Therapeutics Inc. meeting your algorithmic filter criteria2025 Valuation Update & AI Based Buy and Sell Signals - newser.com
Risk vs reward if holding onto Lexeo Therapeutics Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
Lexeo Therapeutics (LXEO) Price Target Increased by 19.77% to 21.29 - Nasdaq
Market Recap: Can Lexeo Therapeutics Inc. stock deliver strong Q4 earningsJuly 2025 Reactions & Real-Time Chart Breakout Alerts - Fundação Cultural do Pará
Lexeo Therapeutics Inc Azioni (LXEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lexeo Therapeutics Inc Azioni (LXEO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Robertson Jenny | Chief Legal Officer |
Oct 17 '25 |
Sale |
8.94 |
3,526 |
31,530 |
68,930 |
| Otero Jose Manuel | Chief Technical Officer |
Oct 17 '25 |
Sale |
8.94 |
2,115 |
18,913 |
64,197 |
| Adler Eric | Chief Medical Officer |
Oct 17 '25 |
Sale |
8.94 |
3,382 |
30,242 |
73,261 |
| Townsend Richard Nolan | Chief Executive Officer |
Oct 17 '25 |
Sale |
8.94 |
13,133 |
117,436 |
242,118 |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):